Cardiovascular Research 1997: Vol 35-36 Index

15 Pages·1997·3.4 MB·English

Cardiovascular
Research
LSEVIER
Cardiovascular Research 36 (1997) 462-466
Keyword Index — volumes 35 + 36
a-Adrenoceptor, (36) 216 Balloon injury, (35) 351
ACE inhibitors, (35) 30 Beta-adrenergic agonists, (36) 67
A10 cells, (36) 118 Beta-adrenergic receptor, (36) 223
Acetylcholine, (35) 132, (35) 377 Blood flow, (36) 268
Acidic fibroblast growth factor (aFGF), (35) 470 Blood pressure, (36) 276
Acidosis, (35) 256 Blood velocity, (35) 125
Acromegaly, (36) 3 Blood velocity profile, (36) 377
Action potential, (35) 13 Brachial artery, (35) 125
Action potential duration, (35) 256, (35) 315 Bradykinin receptors, (35) 138
Adenine nucleotides, (36) 354 Bypass grafts, (35) 505
Adeno-associated virus vector, (35) 514
Adenosine, (35) 168 Ca**-ATPase, (36) 67
Adenosine A, receptor, (36) 52
Calcinosis, (36) 293
Adenosine A , receptor, (36) 52
Calciphylaxis, (36) 293
Adenoviral vector, (35) 553
Calcium channel antagonist, (36) 174
Adenovirus, (35) 391, (35) 422, (35) 442, (35) 480, (35) 505,
Calcium channel, L-type, (35) 294
(35) 529, (35) 536, (35) 560
Calcium current, (35) 315
Adenovirus vector, (35) 451
Calcium, cytosolic concentration, (35) 360
Adenylyl cyclase, (35) 324
Calcium, intracellular concentration, (36) 174
Adhesion, (36) 408
Calcium sensitisers, (36) 10
8-Adrenergic receptor kinase, (35) 324
Calcium sensitivity, (36) 86
Adrenomedullin, (36) 246
Calcium transient, (35) 6, (35) 294
Age, (35) 35
Calpain, (35) 60
Aldosterone, (35) 30
Calpain inhibitors, (35) 60
Alpha v beta 3, (36) 408
Captopril, (36) 236
Amiloride, (36) 337
Cardiac autonomic nervous system, (36) 101
Amiodarone, (35) 13
Cardiac hypertrophy, (36) 363, (36) 452
cAMP, (35) 168, (36) 437
Angiogenesis, (35) 391, (35) 470, (35) 480, (35) 490, (35) 547, Cardiac hypertrophy, compensatory, (35) 6
Cardiac muscle, (36) 10
(36) 78, (36) 276
Cardiac myocyte, (35) 498
Angioplasty, (36) 396
Cardiac neural crest, (36) 163
Angiotensin converting enzyme, (35) 138
Cardiac output, (36) 377
Angiotensin II, (36) 236, (36) 268, (36) 310
Cardiac performance, (36) 3
Angiotensin receptor, (35) 99, (35) 138
Cardiocytes, (36) 216
Animal, (35) 490
Cardiodepression, (35) 68
Anoxia, (35) 256, (35) 273
Cardiomyocyte, (35) 431
ANP, (35) 158
Cardiomyopathy, (35) 184, (35) 217, (35) 422
Antiarrhythmic drugs, (35) 5
Cardioprotection, (35) 567
Aorta, (35) 514
Cardiopulmonary bypass, (36) 223
Aprikalim, (35) 377
Cardiotonic agents, (36) 10
L-Arginine, (35) 351, (36) 429
Cardiovascular disease, (35) 414
Arginine analogs, (35) 148
Catheter, (35) 391
Arrhythmias, (35) 6
Cationic liposomes, (35) 522
Arteries, (36) 268
Cell culture, (35) 498
Astemizole, (35) 341
Cell migration, (36) 118
Atherosclerosis, (35) 391, (35) 490, (36) 28, (36) 256
Cell proliferation, (36) 118
Autogenous vein graft, (35) 360
Cell specific, (35) 498
Autoradiography, (36) 363
Cholesterol, (35) 384, (35) 386
Autoradiography, in vitro, (35) 138
Chronic renal failure, (36) 293
Autoregulation, (35) 368
Cigarette smoking, (35) 250
Cardiovascular
Research
LSEVIER
Cardiovascular Research 36 (1997) 462-466
Keyword Index — volumes 35 + 36
a-Adrenoceptor, (36) 216 Balloon injury, (35) 351
ACE inhibitors, (35) 30 Beta-adrenergic agonists, (36) 67
A10 cells, (36) 118 Beta-adrenergic receptor, (36) 223
Acetylcholine, (35) 132, (35) 377 Blood flow, (36) 268
Acidic fibroblast growth factor (aFGF), (35) 470 Blood pressure, (36) 276
Acidosis, (35) 256 Blood velocity, (35) 125
Acromegaly, (36) 3 Blood velocity profile, (36) 377
Action potential, (35) 13 Brachial artery, (35) 125
Action potential duration, (35) 256, (35) 315 Bradykinin receptors, (35) 138
Adenine nucleotides, (36) 354 Bypass grafts, (35) 505
Adeno-associated virus vector, (35) 514
Adenosine, (35) 168 Ca**-ATPase, (36) 67
Adenosine A, receptor, (36) 52
Calcinosis, (36) 293
Adenosine A , receptor, (36) 52
Calciphylaxis, (36) 293
Adenoviral vector, (35) 553
Calcium channel antagonist, (36) 174
Adenovirus, (35) 391, (35) 422, (35) 442, (35) 480, (35) 505,
Calcium channel, L-type, (35) 294
(35) 529, (35) 536, (35) 560
Calcium current, (35) 315
Adenovirus vector, (35) 451
Calcium, cytosolic concentration, (35) 360
Adenylyl cyclase, (35) 324
Calcium, intracellular concentration, (36) 174
Adhesion, (36) 408
Calcium sensitisers, (36) 10
8-Adrenergic receptor kinase, (35) 324
Calcium sensitivity, (36) 86
Adrenomedullin, (36) 246
Calcium transient, (35) 6, (35) 294
Age, (35) 35
Calpain, (35) 60
Aldosterone, (35) 30
Calpain inhibitors, (35) 60
Alpha v beta 3, (36) 408
Captopril, (36) 236
Amiloride, (36) 337
Cardiac autonomic nervous system, (36) 101
Amiodarone, (35) 13
Cardiac hypertrophy, (36) 363, (36) 452
cAMP, (35) 168, (36) 437
Angiogenesis, (35) 391, (35) 470, (35) 480, (35) 490, (35) 547, Cardiac hypertrophy, compensatory, (35) 6
Cardiac muscle, (36) 10
(36) 78, (36) 276
Cardiac myocyte, (35) 498
Angioplasty, (36) 396
Cardiac neural crest, (36) 163
Angiotensin converting enzyme, (35) 138
Cardiac output, (36) 377
Angiotensin II, (36) 236, (36) 268, (36) 310
Cardiac performance, (36) 3
Angiotensin receptor, (35) 99, (35) 138
Cardiocytes, (36) 216
Animal, (35) 490
Cardiodepression, (35) 68
Anoxia, (35) 256, (35) 273
Cardiomyocyte, (35) 431
ANP, (35) 158
Cardiomyopathy, (35) 184, (35) 217, (35) 422
Antiarrhythmic drugs, (35) 5
Cardioprotection, (35) 567
Aorta, (35) 514
Cardiopulmonary bypass, (36) 223
Aprikalim, (35) 377
Cardiotonic agents, (36) 10
L-Arginine, (35) 351, (36) 429
Cardiovascular disease, (35) 414
Arginine analogs, (35) 148
Catheter, (35) 391
Arrhythmias, (35) 6
Cationic liposomes, (35) 522
Arteries, (36) 268
Cell culture, (35) 498
Astemizole, (35) 341
Cell migration, (36) 118
Atherosclerosis, (35) 391, (35) 490, (36) 28, (36) 256
Cell proliferation, (36) 118
Autogenous vein graft, (35) 360
Cell specific, (35) 498
Autoradiography, (36) 363
Cholesterol, (35) 384, (35) 386
Autoradiography, in vitro, (35) 138
Chronic renal failure, (36) 293
Autoregulation, (35) 368
Cigarette smoking, (35) 250
Keyword Index volumes 35 + 36
Cilazaprilat, (36) 386 Feedback, (36) 437
Collagen, (35) 30, (35) 202, (36) 347 Femoral blood velocities, (36) 372
Collagen phenotypes, (36) 236 Ferret, (35) 60
Collagen remodeling, (35) 223 FGF, (35) 480
Collateral circulation, (35) 377, (35) 547 bFGF, (35) 334, (36) 78
Color Doppler, (36) 377 Fibroblasts, (35) 202
Compliance, (35) 132 Fibrosis, (35) 138
Computer model, (35) 256 Fik-1 /KDR, (36) 276
Conduction, (35) 52 Fit-1, (36) 276
Congenital heart disease, (36) 163 Fluorescence microscopy, (36) 386
Contractile elements, (36) 86 Forearm, (36) 445
Contractile function, (35) 106, (36) 301 Forearm blood flow, (35) 125
Contractility, (36) 223 Free radicals, (35) 68, (35) 334, (36) 185
Coronary artery disease, (35) 250, (36) 21, (36) 330 Free radical scavengers, (35) 68
Coronary artery spasm, (36) 37 Functional studies, (35) 80
Coronary atheroma, (35) 120
Coronary blood flow, (36) 452
Gene-environment interaction, (35) 250
Coronary flow, (35) 303
Gene expression, (35) 223, (35) 414, (35) 522, (36) 28, (36) 256
Coronary flow reserve, (36) 21
Gene therapy, (35) 391, (35) 431, (35) 442, (35) 459, (35) 470,
Coronary microcirculation, (35) 148, (36) 386
(35) 480, (35) 529, (35) 536, (35) 553, (35) 560, (35) 567
Coronary vasculature, (36) 101
Genetics, (36) 134
Creatine kinase, (36) 354
Gene transfer, (35) 324, (35) 490, (35) 498, (35) 505, (35) 514
Cyclic AMP, (36) 223
Glibenclamide, (35) 148, (35) 303
Cyclic GMP, (36) 452
Glucose, (35) 273
Cytokine, (36) 310
GLUT4 translocation, (35) 283
Cytoskeletal proteins, (36) 118
Glycolysis, (35) 90, (35) 273
cGMP, (35) 158, (36) 437
Desethylamiodarone, (35) 13
G proteins, (36) 223
Diabetes mellitus, (35) 303
Growth, (35) 158
Differential display, (35) 414
Growth factor, (35) 490, (35) 547, (36) 78
Dilated cardiomyopathy, (36) 3
Guanylate cyclase inhibition, (36) 452
Diurnal variation, (35) 30
Guinea pig, (35) 315, (36) 185
DNA damage, (36) 205
Guinea-pig, heart, (35) 43, (35) 68
DNA measurement, (36) 45
Guinea pig, ventricular myocytes, (35) 294
DNA polymorphism, (35) 250
Dobutamine, (35) 148, (35) 233
Dobutamine stress test, (36) 323 Hamster, (35) 217
Dog, (36) 78, (36) 337 Heart, (35) 560
Dog, anesthetized, (35) 52, (36) 174, (36) 223 Heart development, (36) 101
Dog, arteries, (35) 377 Heart failure, (35) 30, (36) 3, (36) 10, (36) 163, (36) 246
Dog, skeletal muscle microsomes, (36) 67 Heart rate, (35) 30, (35) 52
Dog, ventricle, (36) 223 Heart rate, variability, (35) 6, (35) 35
Heart transplantation, (35) 529
Echo Doppler, (35) 125 Helicobacter pylori, (35) 120
EDRF, (35) 148 Hemodynamics, (36) 111
Endothelial cell, (35) 498, (35) 514 Heparin, (35) 480
Endothelial cells, (35) 547 Hibernation, (35) 233, (36) 301
Endothelial function, (35) 351 Histamine, (36) 437
Endothelin, (35) 360, (36) 60, (36) 246 HNK-1, (36) 101
Endothelium, (35) 148, (35) 442, (35) 505, (35) 522, (36) 445 Holter ECG, (35) 35
Endothelium-derived factors (nitric oxide), (36) 185 Human, (35) 30, (35) 35, (35) 99, (35) 490, (35) 522, (36) 21,
Energy metabolism, (35) 303 (36) 37, (36) 45, (36) 268, (36) 377, (36) 445
Epidural anesthesia, (36) 111 Human, aorta, (36) 256
ET, /ET, receptor, (35) 360 Human atrium, (36) 52
Excitation—contraction coupling, (35) 294 Human, coronary artery, (35) 241, (36) 28
Exercise, (35) 132 Humans, (36) 246, (36) 330
Expression, (36) 216 HUVECs, (36) 437
Extracellular matrix, (35) 202 Hypercalcemia, (36) 293
Hypercholesterolemia, (36) 429
Familial combined hyperlipidemia, (36) 445 Hypercontracture, (35) 80
Fasting, (35) 90 Hyperkalemia, (35) 256
464 Keyword Index — volumes 35 + 36
Hyperplasia, (35) 351 Mouse, (35) 341
Hypertension, (35) 202 Mouse mutant, (36) 163
Hypertrophy, (35) 315 Myocardial contraction, (36) 185, (36) 337
Hypoxia, (35) 217, (35) 567 Myocardial infarct, (35) 52, (36) 298
Myocardial infarction, (35) 80, (35) 223, (35) 431, (36) 45, (36)
Immunocytochemistry, (36) 363 67
Immunohistochemistry, (35) 223 Myocardial ischemia, (35) 68, (35) 181, (35) 233, (35) 256, (35)
Immunosuppression, (35) 529 490, (36) 67, (36) 174, (36) 298, (36) 301, (36) 323, (36) 337
Indo-1, (35) 294 Myocardial O, consumption, (36) 452
Infarct size, (35) 80 Myocardial stunning, (36) 386
Inotropic agents, (36) 10 Myocardium, (35) 560, (36) 78
Insulin, (35) 90, (35) 303 Myocyte hypertrophy, (36) 347
Integrins, (36) 408 Myocytes, (35) 324
Interleukin-1, (35) 168 Myosin heavy chain, (35) 560
Intracellular calcium, (36) 10 B-Myosin heavy chain, (36) 101
Intracellular compartmentation, (36) 354 Myosin light chain, (35) 560
Intracellular signaling, (35) 283
Intracoronary Doppler flow wire, (36) 21 Na*/Ca?* exchange, (35) 6, (35) 294
Intravital microscopy, (35) 148 Na* /Ca**-exchanger, (36) 216
Ion channel expression, (35) 13 Neointima, (36) 396
Jon channels, (35) 13, (35) 384, (35) 386
Neointimal formation, (35) 351
Ionic currents, (35) 181 Neural tube defects, (36) 163
Ion transport, (35) 384, (35) 386 Neuropeptide-Y, (36) 246
Ischaemia, (36) 372
New Zealand white rabbits, (36) 396
Ischaemic cell death, (36) 60
N®-Nitro-L-arginine, (35) 368
Ischaemic contracture, (36) 354 Nifedipine, (36) 174, (36) 337
Ischemia, (35) 80, (35) 113, (35) 480
Nitrates, (35) 132, (35) 233
Ischemia /reperfusion, (36) 37 Nitric oxide, (35) 148, (35) 168, (35) 368, (35) 377, (36) 60, (36)
Ischemic heart disease, (35) 283, (36) 377
195, (36) 205, (36) 276, (36) 386, (36) 429, (36) 445
Ischemic preconditioning, (36) 52 Nitric oxide donor, (36) 60
Isoproterenol, (35) 106
Nitric oxide synthase, (35) 553
Nitric oxide synthase inhibition, (36) 111
Kawasaki disease, (36) 323 Nitroglycerin, (35) 377
Nitroimidazole, (35) 217
Laser Doppler, (36) 372 Nitrotyrosine, (36) 205
Leukocyte adhesion, (36) 386
NMR, (35) 90
Levcromakalim, (35) 303 Noradrenaline, (35) 132
Lipid hydroperoxides, (36) 330 Norepinephrine, (35) 303
Lipid-lowering therapy, (36) 445 Nuclear hyperplasia, (36) 45
Liposomes, (35) 391
Lisinopril, (36) 236
Long QT, (35) 422 B-Oxidation, (35) 184
Loratadine, (35) 341 Oxidative metabolism, (35) 184
Losartan, (35) 223, (36) 268 Oxidative phosphorylation, (35) 273
Low density lipoprotein, (36) 92 Oxygen radicals, (36) 205
Ltk~ cells, (35) 341
Pacing, (35) 113
Magnesium, (35) 43 Particle bombardment, (35) 522
Magnetic resonance velocity mapping, (36) 377 Patch clamp, (35) 273, (35) 341
MAP kinase, (35) 158, (36) 310 Pax, (36) 163
Mapping, (35) 52 PDGF, (36) 118
MDL-28170, (35) 60 Percutaneous coronary revascularization, (35) 405
Membrane excitability, (35) 256 Peroxynitrite, (36) 195, (36) 205
Metabolism, (35) 90 p53 gene, (35) 250
Methylene blue, (35) 368 Pharmacodynamics, (36) 78
Microcirculation, (35) 217, (36) 372 Phenotype, (35) 6
Microvessels, (35) 547 Phosphatidylinositol 3-kinase, (35) 283
Migration, (36) 408 Phosphocreatine, (36) 354
Milk-alkali syndrome, (36) 293 Phospholamban, (35) 106, (36) 67
Mitochondrial DNA, (35) 184 Photodynamic therapy, (35) 334
Mitochondrial function, 28°C, (35) 113 Pig, anesthetized, (35) 233
Keyword Index — volumes 35 + 36
PKC,, (35) 60 Sarcolemma, (35) 384, (35) 386
PKM,,, (35) 60 Sarcoplasmic reticulum, (35) 294, (36) 67
Plaque stabilization, (35) 391 Sepsis, (35) 368
Plasma, (36) 246 Sheep, (36) 111
Plasminogen, (35) 241 Signal-averaged electrocardiography, (36) 323
Plasminogen activator inhibitor-1, (35) 241, (36) 28 Signal peptide, (35) 470
Polyploidization, (36) 45 Signal transduction, (36) 310
Porcine coronary, (36) 408 Smooth muscle, (35) 505
Porcine coronary artery, (35) 553 Smooth muscle cell, (35) 334, (35) 442, (35) 514, (36) 92
Positive pressure, (36) 372 Sodium depletion, (36) 268
Potassium channel, ATP-sensitive, (35) 148, (35) 181, (35) 256, Soluble adhesion molecule, (36) 37
(35) 273, (35) 303, (35) 377 Sotalol, (35) 43
Potassium channel, hKv1.5, (35) 341 d-Sotalol, (35) 52
Potassium channel opener, (35) 303, (35) 377 Spectral analysis, (35) 35
Preconditioning, (36) 298 Spironolactone, (35) 30
Prolyl 4-hydroxylase, (35) 223 Splotch, (36) 163
Promoter, (35) 560 Spontaneously hypertensive rat, (36) 86
Protein analysis, (36) 174 SR Ca**-ATPase, (35) 106
Protein kinase C, (36) 86, (36) 310 Stent, (36) 408
Pulmonary artery, (36) 377 Stunned myocardium, (36) 337
Pulsed Doppler, (35) 125 Stunning, (35) 60, (35) 113, (36) 298
Stunning arrhythmias, (36) 174
QT interval, (35) 43 Sulfonylureas, (35) 303
Quail, (36) 101 Sympathetic nerve activity, (36) 111
Sympathetic nervous system, (35) 30, (35) 35
Rabbit, (35) 536, (36) 276, (36) 452 Syrian hamster, (35) 217
Rabbit, endothelial cells, (35) 505
Rabbit, genetically hyperlipidemic, (35) 351 TBARS, (36) 330
Rabbit, heart, (35) 113 T-cell receptor, (36) 256
Rabbit, saphenous vein, (35) 360 Terfenadine, (35) 341
Radioimmune assay, (35) 158 Tetraethylammonium, (35) 377
Rat, (35) 168, (35) 431, (35) 547, (35) 560, (36) 60, (36) 118, Therapeutic target, (35) 414
(36) 216, (36) 236, (36) 363 Thrombin, (36) 92
Rat, arteries, (35) 132 Thrombosis, (35) 120, (35) 459
Rat, atrium, (35) 106 Thyroid hormone, (35) 13, (35) 106
Rat, heart, (35) 90, (35) 303, (35) 368 T-lymphocytes, (36) 256
Rat myocardial infarction, (36) 347 a-Tocopherol, (36) 330
Rat, Sprague-Dawley, (35) 283 Transcription factor, (35) 536
Rat, vascular smooth muscle cells, (35) 158 Transesophageal echocardiography, (36) 21
Rat, ventricle, (35) 223 Transfection, (35) 522
Rat ventricular cells, (36) 354 Tyrosine kinase, (36) 310
Raynaud’s phenomenon, (35) 175
Reactive hyperemia, (35) 368 Unstable angina, (36) 37
Receptors, (35) 158 Urokinase, (35) 241
Recombinant adenovirus, (35) 498 Use dependence, (35) 43
Recombinant Semliki Forest virus, (35) 498
Redox, (35) 567 Variant angina, (36) 37
Refractory period, (35) 52 Vascular disease, (35) 451
Regression of Hypertrophy, (36) 236 Vascular endothelial growth factor, (36) 276
Remodeling, (36) 396, (36) 408 Vascular endothelium, (36) 60
Renal hypertension, (36) 452 Vascular injury, (35) 351
Reoxygenation, (35) 273 Vascular reactivity, (35) 132
Reperfusion, (35) 68, (36) 174, (36) 347 Vascular smooth muscle, (35) 360, (36) 86, (36) 118
Reperfusion arrhythmias, (35) 80, (36) 337 Vascular smooth muscle cell, (35) 168, (35) 498
Reperfusion injury, (35) 80, (36) 60, (36) 195, (36) 337 Vascular smooth muscle cell proliferation, (35) 158
Repolarization, (35) 43 Vasculogenesis, (35) 490
Respiratory chain, (35) 184 Vasoconstriction, (35) 125
Restenosis, (35) 391, (35) 405, (35) 536, (36) 396, (36) 408 Vasodilation, (35) 125
Retroinfusion, (35) 233 Vasomotor function, (35) 553
mRNA, (35) 99, (35) 360 VEGF, (35) 480
RT-PCR, (35) 99 Vein graft, (35) 442, (36) 429
466 Keyword Index — volumes 35 + 36
Ventricular fibrillation, (36) 174 Williams syndrome, (36) 134
Ventricular myocyte, (35) 273, (35) 315 Wistar-Kyoto rat, (36) 86, (36) 276
Ventricular remodeling, (36) 347 Wortmannin, (35) 283
Vitamin D toxicity, (36) 293
Volume overload, (36) 363
Cardiovascular
Research
Cardiovascular Research 36 (1997) 467-474
Author Index — volumes 35 + 36
Abraham, P., see Fromy, B. (36) 372 blockade on vasoconstrictive properties of nitric oxide synthase
Addicks, K., see Hescheler, J. (36) 149 inhibition in sheep (36) 111
Ader, J.-L., see Malavaud, B. (36) 276 Boon, N.A., see Newby, D.E. (36) 268
Adili, F., see Statius van Eps, R.G. (35) 334 Bowles, N.E., Wang, Q. and Towbin, J.A., Prospects for
Adler, C.P., see Herget, G.W. (36) 45 adenovirus-mediated gene therapy of inherited diseases of the
Allen, D.G., see Lee, J.A. (36) 10 myocardium (35) 422
Anand-Srivastava, M.B., see Dupuis, J.-Y. (36) 223
Anderson, R.H., see Conway, S.J. (36) 163 Branellec, D., see Maillard, L. (35) 536
Angelini, G.D., see Baker, A.H. (35) 442 Braunholtz, D., see Ossei-Gerning, N.
Annex, B.H., see Channon, K.M. (35) 505 Brieger, D. and Topol, E., Local drug delivery systems and
Antipenko, A.Y. and Kirchberger, M.A., Membrane prevention of restenosis (35) 405
phosphorylation protects the cardiac sarcoplasmic reticulum Brooks, L.A., see Embrey, R.P. (35) 148
Ca**-ATPase against chlorinated oxidants in vitro (36) 67 Brooks, L.A., see Lamping, K.G. (35) 377
Antozzi, C. and Zeviani, M., Cardiomyopathies in disorders of Brosius III, F.C., see Egert, S. (35) 283
oxidative metabolism (35) 184 Brown, L.A., Rutherford, R.A.D., Nunez, D.J.R., Wharton, J.,
Antzelevitch, C., Are M cells present in the ventricular Lowe, D.G. and Wilkins, M.R., Downregulation of natriuretic
myocardium of the pig? A question of maturity (36) 127 peptide C-receptor protein in the hypertrophied ventricle of
Arita, M., see Shigematsu, S. (35) 273 the aortovenocaval fistula rat (36) 363
Arnold, P.J., see Kingwell, B.A. (35) 132 Bruggeman, C.A., see Persoons, M.C.J. (36) 282
Avontuur, J.A.M., Bruining, H.A. and Ince, C., Nitric oxide Bruining, H.A., see Avontuur, J.A.M. (35) 368
causes dysfunction of coronary autoregulation in endotoxemic Brunner, F., Leonhard, B., Kukovetz, W.R. and Mayer, B., Role
rats (35) 368 of endothelin, nitric oxide and L-arginine release in
Axon, A.T.R., see Ossei-Gerning, N. (35) 120 ischaemia /reperfusion injury of rat heart (36) 60
Bryant, S.M., Shipsey, S.J. and Hart, G., Regional differences in
Baker, A.H., Mehta, D., George, S.J. and Angelini, G.D.,
electrical and mechanical properties of myocytes from guinea-
Prevention of vein graft failure: potential applications for gene
pig hearts with mild left ventricular hypertrophy (35) 315
therapy (35) 442
Banai, S., see Gertz, $.D. (36) 396
Banga, J.-D., see Stroes, E. (36) 445 Cable, D.G., O’Brien, T., Kullo, I.J., Schwartz, R.S., Schaff,
Barr, C.S., see MacFadyen, R.J. (35) 30 H.V. and Pompili, V.J., Expression and function of a
Barrabés, J.A., see Garcia-Dorado, D. (35) 80 recombinant endothelial nitric oxide synthase gene in porcine
Barry, J.J., see Maillard, L. (35) 536 coronary arteries (35) 553
Barry, W.L., see Gertz, S.D. (36) 396 Calderone, A., see Dupuis, J.-Y. (36) 223
Barzilai, B., see Courtois, M. (35) 206 Cales, P., see Fromy, B. (36) 372
Bauer, A., see Freigang, K.D. (35) 52 Cannell, M.B., see Evans, A.M. (35) 294
Baumann, G., see Felix, S.B. (35) 68 Capogrossi, M.C., see Melillo, G. (35) 480
Baumgartner, H., see Zehetgruber, M. (36) 21 Carlyle, W., see McDonald, K. (36) 347
Becker, B.F., see Kupatt, C. (36) 386 Carr, C.S., Hill, R.J.. Masamune, H., Kennedy, S.P., Knight,
Becker, R., see Freigang, K.D. (35) 52 D.R., Tracey, W.R. and Yellon, D.M., Evidence for a role for
Berndt, T., see Felix, S.B. (35) 68 both the adenosine A, and A, receptors in protection of
Binder, T., see Zehetgruber, M. (36) 21 isolated human atrial muscle against simulated ischaemia (36)
Bishopric, N.H., see Prentice, H. (35) 567 52
Blanco, J., see Garcia-Dorado, D. (35) 80 Carr, D.P., see Tanner, F.C. (35) 522
Blazing, M.A., see Channon, K.M. (35) 505 Carré, F., see Swynghedauw, B. (35) 6
Boekstegers, P., see Von Degenfeld, G. (35) 233 Channon, K.M., Fulton, G.J., Gray, J.L., Annex, B.H., Shetty,
Bolz, S.-S. and Pohl, U., Indomethacin enhances endothelial NO G.A., Blazing, M.A., Peters, K.G., Hagen, P.-O. and George,
release — evidence for a role of PGI, in the autocrine control S.E., Efficient adenoviral gene transfer to early venous bypass
of calcium-dependent autacoid production (36) 437 grafts: comparison with native vessels (35) 505
Bone, H.-G., see Booke, M. (36) 111 Charlemagne, D., see Swynghedauw, B. (35) 6
Booke, M., Waurick, R., Van Aken, H., Bone, H.-G., Meifner, Chevalier, B., see Swynghedauw, B. (35) 6
A., Prien, T. and Meyer, J., Effects of sympathetic nerve Christ, G., see Zehetgruber, M. (36) 21
468 Author Index — volumes 35 + 36
Christopher, T.A., see Ma, X.L. (36) 195 Eschenhagen, T., see Roks, A.J.M. (35) 498
Chu, C., see McDonald, K. (36) 347 Eto, K., see Takeshita, S. (35) 547
Cintron, G., see Daggubati, S. (36) 246 Evans, A.M. and Cannell, M.B., The role of L-type Ca”* current
Collen, D., see Gerard, R.D. (35) 451 and Na™ current-stimulated Na/Ca exchange in triggering SR
Colosi, P., see Maeda, Y. (35) 514 calcium release in guinea-pig cardiac ventricular myocytes
Conway, S.J., Henderson, D.J., Kirby, M.L., Anderson, R.H. and (35) 294
Copp, A.J., Development of a lethal congenital heart defect in
the splotch ( Pax3) mutant mouse (36) 163 Feldman, L.J. and Steg, G., Optimal techniques for arterial gene
Copp, A.J., see Conway, S.J. (36) 163 transfer (35) 391
Coronel, R., see Levi, M. (35) 389 Felix, $.B., Stangl, V., Frank, T.M., Harms, C., Berndt, T.,
Courtois, M., Barzilai, B., Hall, A.F. and Ludbrook, P.A., Kastner, R. and Baumann, G., Release of a stable
Postextrasystolic left ventricular isovolumic pressure decay is cardiodepressant mediator after myocardial ischaemia during
not monoexponential (35) 206 reperfusion (35) 68
Cunanan, D.B., see Hutchinson, H.G. (35) 158 Ferrari, R., The new ischemic syndromes—an old phenomenon
Cuzzocrea, S., see Zingarelli, B. (36) 205 disguised with a new glossary? (36) 298
Ferrari, R., see Heusch, G. (36) 301
Dadhania, D.M., see Lazarous, D.F. (36) 78 Feuerstein, G.Z., see Wang, X. (35) 414
Daemen, M.J.A.P., see Persoons, M.C.J. (36) 282 Fielitz, J., see Regitz-Zagrosek, V. (35) 99
Daggubati, S., Parks, J.R., Overton, R.M., Cintron, G., Schocken, Fitzpatrick, L.A., see Srivatsa, S.S. (36) 408
D.D. and Vesely, D.L., Adrenomedullin, endothelin, Fleck, E., see Regitz-Zagrosek, V. (35) 99
neuropeptide Y, atrial, brain, and C-natriuretic prohormone Fleischmann, B.K., see Hescheler, J. (36) 149
peptides compared as early heart failure indicators (36) 246 Flugelman, M.Y., see Lewis, B.S. (35) 490
Dahmann, R., see Kelm, M. (36) 185 Francis, G., see McDonald, K. (36) 347
Dart, A.M., see Kingwell, B.A. (35) 132 Frank, T.M., see Felix, $.B. (35) 68
De Bruin, T., see Stroes, E. (36) 445 Franqueza, L., see Delpon, E. (35) 341
Decking, U.K.M., see Kelm, M. (36) 185 Franz, W.-M., Rothmann, T., Frey, N. and Katus, H.A., Analysis
Dellsperger, K.C., see Embrey, R.P. (35) 148 of tissue-specific gene delivery by recombinant adenoviruses
Delpon, E., Valenzuela, C., Gay, P., Franqueza, L., Snyders, D.J. containing cardiac-specific promoters (35) 560
and Tamargo, J., Block of human cardiac Kv1.5 channels by Freigang, K.D., Bauer, A., Becker, R., Senges, J.C., Kraft, P.,
loratadine: voltage-, time- and use-dependent block at Brachmann, J., Kiibler, W. and Schoels, W., Differential
concentrations above therapeutic levels (35) 341 effects of d-sotalol on normal and infarcted myocardium: an
Denéfle, P., see Maillard, L. (35) 536 experimental study using epicardial mapping (35) 52
De Valk, H., see Stroes, E. (36) 445 Frey, N., see Franz, W.-M. (35) 560
Dichek, D.A., see Vassalli, G. (35) 459 Frohlich, O. and Karmazyn, M., The Na—H exchanger revisited:
Diez, J. and Laviades, C., Monitoring fibrillar collagen turnover an update on Na—H exchange regulation and the role of the
in hypertensive heart disease (35) 202 exchanger in hypertension and cardiac function in health and
Digerness, S.B., see Urthaler, F. (35) 60 disease (36) 138
Discher, D.J., see Prentice, H. (35) 567 Fromy, B., Legrand, M.-S., Abraham, P., Leftheriotis, G., Cales,
Dixon, I.M.C., see Ju, H. (35) 223 P. and Saumet, J.-L., Effects of positive pressure on both
Dolu, B., see Kelm, M. (36) 185 femoral venous and arterial blood velocities and the cutaneous
Drexler, H., see Reinecke, H. (36) 216 microcirculation of the forefoot (36) 372
Dreysse, R., see Regitz-Zagrosek, V. (35) 99 Fujii, M., see Lamping, K.G. (35) 377
Dupuis, J.-Y., Li, K., Calderone, A., Gosselin, H., Yang, X.-P., Fujiwara, T., see Watanabe, Y. (35) 217
Anand-Srivastava, M.B., Teijeira, J. and Rouleau, J.-L., B- Fukuchi, K., see Watanabe, Y. (35) 217
Adrenergic signal transduction and contractility in the canine Fulton, G.J., see Channon, K.M. (35) 505
heart after cardiopulmonary bypass (36) 223
Garcia-Dorado, D., Gonzalez, M.A., Barrabés, J.A., Ruiz-Meana,
Egert, S., Nguyen, N., Brosius III, F.C. and Schwaiger, M., M., Solares, J., Lidon, R.-M., Blanco, J., Puigfel, Y., Piper,
Effects of wortmannin on insulin- and ischemia-induced H.M. and Soler-Soler, J., Prevention of ischemic rigor
stimulation of GLUT4 translocation and FDG uptake in contracture during coronary occlusion by inhibition of Na*—
perfused rat hearts (35) 283 H* exchange (35) 80
Eguchi, D., Nishimura, J., Kobayashi, S., Komori, K., Sugimachi, Garovoy, N., see Oksenberg, J.R. (36) 256
K. and Kanaide, H., Down-regulation of endothelin B receptors Garvin, M.R., Labinaz, M., Pels, K., Walley, V.M., Mizgala,
in autogenous saphenous veins grafted into the arterial H.F. and O’Brien, E.R., Arterial expression of the plasminogen
circulation (35) 360 activator system early after cardiac transplantation (35) 241
Eguchi, D., see Okazaki, J. (36) 429 Gay, P., see Delpoén, E. (35) 341
Embrey, R.P., Brooks, L.A. and Dellsperger, K.C., Mechanism Genma, Y., Ogawa, S., Zhang, J. and Yamamoto, M., Evaluation
of coronary microvascular responses to metabolic stimulation of myocardial ischemia in Kawasaki disease by dobutamine
(35) 148 stress signal-averaged ventricular late potentials (36) 323
Erkelens, W., see Stroes, E. (36) 445 George, S.E., see Channon, K.M. (35) 505
Erusalimsky, J.D., see Oksenberg, J.R. (36) 256 George, S.J., see Baker, A.H. (35) 442
Author Index — volumes 35 + 36
Gerard, R.D. and Collen, D., Adenovirus gene therapy for Houlind, K.C., see Sloth, E. (36) 377
hypercholesterolemia, thrombosis and restenosis (35) 451 Howie, G., see Whidden, P. (35) 175
Gerlach, E., see Kupatt, C. (36) 386 Huber, K., see Kostner, K. (36) 330
Gertz, S.D., Barry, W.L., Gimple, L.W., Banai, S., Perez, L.S., Hughson, R.L., see Shoemaker, J.K. (35) 125
McNamara, C.A., Powers, E.R., Ragosta, M., Owens, G.K., Hungerford, J.E., see Vrancken Peeters, M.-P.F.M. (36) 101
Roberts, W.C. and Sarembock, I.J., Predictors of luminal Hutchinson, H.G., Trindade, P.T., Cunanan, D.B., Wu, C.-F. and
narrowing by neointima after angioplasty in atherosclerotic Pratt, R.E., Mechanisms of natriuretic-peptide-induced growth
rabbits (36) 396 inhibition of vascular smooth muscle cells (35) 158
Giehrl, W., see Von Degenfeld, G. (35) 233
Gimple, L.W., see Gertz, S.D. (36) 396 Igawa, A., see Miwa, K. (36) 37
Gittenberger-de Groot, A.C., see Vrancken Peeters, M.-P.F.M. Igel, G., see Yeragani, V.K. (35) 35
(36) 101 Ikeda, U., Kurosaki, K., Ohya, K.-i. and Shimada, K., Adenosine
Glogar, D., see Kostner, K. (36) 330 stimulates nitric oxide synthesis in vascular smooth muscle
Gonzalez, M.A., see Garcia-Dorado, D. (35) 80 cells (35) 168
Gosselin, H., see Dupuis, J.-Y. (36) 223 Ikeda, U., see Maeda, Y. (35) 514
Grant, P.J., see Ossei-Gerning, N. (35) 120 Ince, C., see Avontuur, J.A.M. (35) 368
Grauls, G.E.L.M., see Persoons, M.C.J. (36) 282 Inoue, H., see Miwa, K. (36) 37
Gray, J.L., see Channon, K.M. (35) 505 Ischiropoulos, H., see Ma, X.L. (36) 195
Greenlees, C., Wadsworth, R.M., Martorana, P.A. and Ishida, M., see Okazaki, J. (36) 429
Wainwright, C.L., The effects of L-arginine on neointimal Isner, J.M., see Maillard, L. (35) 536
formation and vascular function following balloon injury in Isner, J.M., see Tabata, H. (35) 470
heritable hyperlipidaemic rabbits (35) 351 Isshiki, T., see Takeshita, S. (35) 547
Gschwendt, S., see Roks, A.J.M. (35) 498
Habazettl, H., see Kupatt, C. (36) 386 Jassal, D.S., see Ju, H. (35) 223
Hagen, P.-O., see Channon, K.M. (35) 505 Jennings, G.L., see Kingwell, B.A. (35) 132
Hall, A.F., see Courtois, M. (35) 206 Jeong, M.C., see Oksenberg, J.R. (36) 256
Hammel, D., see Padré, T. (36) 28 Johnston, N.R., see Newby, D.E. (36) 268
Hamsten, A., see Malmberg, K. (36) 460 Jonca, F., see Malavaud, B. (36) 276
Hano, T., see Sasajima, H. (36) 86 Jones, L.R., see Smart, S.C. (36) 174
Harms, C., see Felix, $.B. (35) 68 Ju, H., Zhao, S., Jassal, D.S. and Dixon, I.M.C., Effect of AT,
Harris, K.D., see Urthaler, F. (35) 60 receptor blockade on cardiac collagen remodeling after
Hart, G., see Bryant, S.M. (35) 315 myocardial infarction (35) 223
Hartman, M., see McDonald, K. (36) 347 Judd, D., see McDonald, K. (36) 347
Hasenkam, J.M., see Sloth, E. (36) 377
Hauer, K., see McDonald, K. (36) 347 Kaasik, A., Paju, K., Vetter, R. and Seppet, E.K., Thyroid
Hearse, D.J., see Heusch, G. (36) 301 hormones increase the contractility but suppress the effects of
Heiden, U., see Stark, G. (35) 43 8-adrenergic agonist by decreasing phospholamban expression
Henderson, D.J., see Conway, S.J. (36) 163 in rat atria (35) 106
Herget, G.W., Neuburger, M., Plagwitz, R. and Adler, C.P., Kamiya, K., see Kodama, I. (35) 13
DNA content, ploidy level and number of nuclei in the human Kanaide, H., see Eguchi, D. (35) 360
heart after myocardial infarction (36) 45 Kandaswamy, V., see Yang, C.M. (36) 236
Herlitz, J., see Malmberg, K. (36) 460 Karmazyn, M., see Frohlich, O. (36) 138
Hescheler, J., Fleischmann, B.K., Lentini, S., Maltsev, V.A., Kistner, R., see Felix, $.B. (35) 68
Rohwedel, J., Wobus, A.M. and Addicks, K., Embryonic stem Katus, H.A., see Franz, W.-M. (35) 560
cells: a model to study structural and functional properties in Kawasaki, K., see Okazaki, J. (36) 429
cardiomyogenesis (36) 149 Kay, J., see Yeragani, V.K. (35) 35
Heusch, G., Ferrari, R., Hearse, D.J., Ruigrok, T.J.C. and Schulz, Kayo, S., see Higuchi, M. (35) 303
R., ‘Myocardial hibernation’—dquestions and controversies Keating, M.T., On the trail of genetic culprits in Williams
(36) 301 syndrome (36) 134
Hicks, M.N., see Prentice, H. (35) 567 Kedes, L.K., see Leor, J. (35) 431
Higuchi, M., Miyagi, K., Kayo, S. and Sakanashi, M., Kelm, M., Schafer, S., Dahmann, R., Dolu, B., Perings, S.,
Acceleration of stiffness in underperfused diabetic rat hearts Decking, U.K.M., Schrader, J. and Strauer, B.E., Nitric oxide
by glyburide, a K,7p channel blocker, and its prevention by induced contractile dysfunction is related to a reduction in
levcromakalim and insulin (35) 303 myocardial energy generation (36) 185
Hildebrandt, A.G., see Regitz-Zagrosek, V. (35) 99 Kennedy, S.P., see Carr, C.S. (36) 52
Hill, R.J., see Carr, C.S. (36) 52 Keren-Tal, I., see Lewis, B.S. (35) 490
Hodge, E., see Lazarous, D.F. (36) 78 Kerr, D.N.S., Hypercalcemia and metastatic calcification (36)
Hoffmann, K., see Laugwitz, K.-L. (35) 324 293
Holmes Jr., D.R., see Srivatsa, S.S. (36) 408 Kienast, J., see Padré, T. (36) 28
Hornykewycz, S., see Kostner, K. (36) 330 Kimura, K., see Sasajima, H. (36) 86
470 Author Index — volumes 35 + 36
Kingwell, B.A., Arnold, P.J., Jennings, G.L. and Dart, A.M.., Lewis, B.S., Flugelman, M.Y., Weisz, A., Keren-Tal, I. and
Spontaneous running increases aortic compliance in Wistar- Schaper, W., Angiogenesis by gene therapy: a new horizon
Kyoto rats (35) 132 for myocardial revascularization? (35) 490
Kirby, M.L., see Conway, S.J. (36) 163 Li, C.-X., see Padré, T. (36) 28
Kirchberger, M.A., see Antipenko, A.Y. (36) 67 Li, K.. see Dupuis, J.-Y. (36) 223
Kloner, R.A., see Leor, J. (35) 431 Lidon, R.-M., see Garcia-Dorado, D. (35) 80
Knight, D.R., see Carr, C.S. (36) 52 Lijnen, P., The effect of membrane cholesterol content on ion
Ko, Y., see Seewald, S. (36) 92 transport processes in plasma membranes (35) 384
Kobayashi, S., see Eguchi, D. (35) 360 Little, C.D., see Vrancken Peeters, M.-P.F.M. (36) 101
Kodama, I., Kamiya, K. and Toyama, J., Cellular Liu, G.-L., see Ma, X.L. (36) 195
electropharmacology of amiodarone (35) 13 Lopez, B.L., see Ma, X.L. (36) 195
Komori, K., see Eguchi, D. (35) 360 Lowe, D.G., see Brown, L.A. (36) 363
Komori, K., see Okazaki, J. (36) 429 Ludbrook, P.A., see Courtois, M. (35) 206
Koomans, H., see Stroes, E. (36) 445
Kostner, K., Hornykewycz, S., Yang, P., Neunteufl, T., Glogar, Ma, X.L., Lopez, B.L., Liu, G.-L., Christopher, T.A. and
D., Weidinger, F., Maurer, G. and Huber, K., Is oxidative Ischiropoulos, H., Peroxynitrite aggravates myocardial
stress causally linked to unstable angina pectoris? A study in reperfusion injury in the isolated perfused rat heart (36) 195
100 CAD patients and matched controls (36) 330 MacDonald, M.J., see Shoemaker, J.K. (35) 125
Kovesdi, I., see Melillo, G. (35) 480 MacFadyen, R.J., Barr, C.S. and Struthers, A.D., Aldosterone
Kraft, P., see Freigang, K.D. (35) 52 blockade reduces vascular collagen turnover, improves heart
Kronsbein, K., see Laugwitz, K.-L. (35) 324 rate variability and reduces early morning rise in heart rate in
Kruse, M., see Sloth, E. (36) 377 heart failure patients (35) 30
Kiibler, W., see Freigang, K.D. (35) 52 Maeda, Y., Ikeda, U., Ogasawara, Y., Urabe, M., Takizawa, T.,
Kukovetz, W.R., see Brunner, F. (36) 60 Saito, T., Colosi, P., Kurtzman, G., Shimada, K. and Ozawa,
Kullo, I.J., see Cable, D.G. (35) 553 K., Gene transfer into vascular cells using adeno-associated
Kupatt, C., Habazettl, H., Zahler, S., Weber, C., Becker, B.F., virus (AAV) vectors (35) 514
Messmer, K. and Gerlach, E., ACE-inhibition prevents Maillard, L., Van Belle, E., Smith, R.C., Le Roux, A., Denéfle,
postischemic coronary leukocyte adhesion and leukocyte- P., Steg, G., Barry, J.J., Branellec, D., Isner, J.M. and Walsh,
dependent reperfusion injury (36) 386 K., Percutaneous delivery of the gax gene inhibits vessel
Kurosaki, K., see Ikeda, U. (35) 168 stenosis in a rabbit model of balloon angioplasty (35) 536
Kurtzman, G., see Maeda, Y. (35) 51 Malavaud, B., Tack, I., Jonca, F., Praddaude, F., Moro, F., Ader,
Kusuoka, H., see Watanabe, Y. J.-L. and Plouét, J., Activation of Flk-1/KDR mediates
angiogenesis but not hypotension (36) 276
Labinaz, M., see Garvin, M.R. (35) 241 Malmberg, K., Rydén, L., Hamsten, A., Herlitz, J., Waldenstrém,
Lamping, K.G., Nuno, D.W., Brooks, L.A. and Fujii, M., A. and Wedel, H., Corrigendum to **Mortality prediction in
Response of coronary microvascular collaterals to activation diabetic patients with myocardial infarction: experiences from
of ATP-sensitive K* channels (35) 377 the DIGAMI study”’ [Cardiovasc. Res. 1997;34:248-253] (36)
LaMuraglia, G.M., see Statius van Eps, R.G. (35) 334 460
Laugwitz, K.-L., Kronsbein, K., Schmitt, M., Hoffmann, K., Maltsev, V.A., see Hescheler, J. (36) 149
Seyfarth, M., Schémig, A. and Ungerer, M., Characterization Mansier, P., see Swynghedauw, B. (35) 6
and inhibition of f-adrenergic receptor kinase in intact Martorana, P.A., see Greenlees, C. (35) 351
myocytes (35) 324 Masamune, H., see Carr, C.S. (36) 52
Laviades, C., see Diez, J. (35) 202 Masumori, S., see Newby, D.E. (36) 268
Lazarous, D.F., Shou, M., Stiber, J.A., Dadhania, D.M., Matrougui, K., see Veksler, V.I. (36) 354
Thirumurti, V., Hodge, E. and Unger, E.F., Pharmacodynamics Maurer, G., see Kostner, K. (36) 330
of basic fibroblast growth factor: route of administration Maurer, G., see Zehetgruber, M. (36) 21
determines myocardial and systemic distribution (36) 78 Mayer, B., see Brunner, F. (36) 60
Lechene, P., see Veksler, V.I. (36) 354 McDonald, K., Chu, C., Francis, G., Judd, D., Carlyle, W..,
Lee, J.A. and Allen, D.G., Calcium sensitisers: mechanisms of Toher, C., Hauer, K. and Hartman, M., The effect of delayed
action and potential usefulness as inotropes (36) 10 reperfusion following infarction in the rat on structural changes
Leftheriotis, G., see Fromy, B. (36) 372 in viable myocardium (36) 347
Legrand, M.-S., see Fromy, B. (36) 372 McGregor, C.G.A., see Yap, J. (35) 529
Lentini, S., see Hescheler, J. (36) 149 McNamara, C.A., see Gertz, S.D. (36) 396
Leonhard, B., see Brunner, F. (36) 60 Mehta, D., see Baker, A.H. (35) 442
Leor, J., Prentice, H., Sartorelli, V., Quinones, M.J., Patterson, MeiBner, A., see Booke, M. (36) 111
M., Kedes, L.K. and Kloner, R.A., Gene transfer and cell Melillo, G., Scoccianti, M., Kovesdi, I., Safi Jr., J., Riccioni, T.
transplant: an experimental approach to repair a ‘broken and Capogrossi, M.C., Gene therapy for collateral vessel
heart’ (35) 431 development (35) 480
Le Roux, A., see Maillard, L. (35) 536 Mentink, M.M.T., see Vrancken Peeters, M.-P.F.M. (36) 101
Levi, M. and Coronel, R., Gene Therapy in the Cardiovascular Messmer, K., see Kupatt, C. (36) 386
System (35) 389 Mesters, R.M., see Padré, T. (36) 28